Labcorp EPS - Earnings per Share 2010-2025 | LH

Labcorp earnings per share (EPS) for the twelve months ending March 31, 2025 was $8.67, a 71.01% increase year-over-year.

  • Labcorp EPS for the quarter ending March 31, 2025 was $2.52, a 6.32% decline year-over-year.
  • Labcorp 2024 annual EPS was $8.84, a 85.32% increase from 2023.
  • Labcorp 2023 annual EPS was $4.77, a 65.86% decline from 2022.
  • Labcorp 2022 annual EPS was $13.97, a 42.72% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Labcorp EPS - Earnings per Share 2010-2025 | LH

  • Labcorp EPS for the quarter ending March 31, 2025 was $2.52, a 6.32% decline year-over-year.
  • Labcorp 2024 annual EPS was $8.84, a 85.32% increase from 2023.
  • Labcorp 2023 annual EPS was $4.77, a 65.86% decline from 2022.
  • Labcorp 2022 annual EPS was $13.97, a 42.72% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$87.4B
Becton Dickinson (BDX)$57.1B
Cardinal Health (CAH)$32.5B
Straumann Holding AG (SAUHY)$18.7B
Cooper (COO)$15.9B
West Pharmaceutical Services (WST)$14.6B
Align Technology (ALGN)$12.5B
Henry Schein (HSIC)$7.9B
Merit Medical Systems (MMSI)$5.4B
Patterson (PDCO)$2.8B
DENTSPLY SIRONA (XRAY)$2.6B
CONMED (CNMD)$1.5B
STAAR Surgical (STAA)$833M
Pro-Dex (PDEX)$198M
Lifevantage (LFVN)$169M